Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ingeborg Schütz
Observed names:
I SCHUETZ,
I Schütz,
I. Schütz
Observed institutions:
Ostalb-Klinikum Aalen,
BDH-Klinik Hessisch Oldendorf
OpenAlex ID:
A5008701384
Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).
1985
·
K Bartmann
, M Fooke-Achterrath
, et al.
·
PubMed
·
42
A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. Preliminary results of the third cooperative study of the WATL.
1969
·
I Schütz
·
PubMed
·
5
Von der Phthisiologie zur Pneumologie und Thoraxchirurgie 60 Jahre Lungenklinik Heckeshorn
2007
·
Vera Seehausen
, Torsten T. Bauer
, et al.
·
Thieme eBooks
·
4
Bacteriological and biochemical criteria for the diagnosis of bacterial infections in chronic obstructive pulmonary disease (COPD)
1984
·
K. Bartmann
, M. Fooke-Achiterrath
, et al.
·
Infection
·
4
Problematik der Ethambutol-Dosierung
1971
·
I. Schütz
·
Lung
·
4
[ethionamide in Double or Triple Combination in Chronic Pretreated Cavernous Pulmonary Tuberculosis].
1964
·
I SCHUETZ
, K BARTMANN
·
PubMed
·
4
Über die Behandlung der kavernösen Lungentuberkulose mit Aethioniamid1
1961
·
Ingeborg Schütz
·
DMW - Deutsche Medizinische Wochenschrift
·
4
Vergleich der Verträglichkeit von Prothionamid und Ethionamid im Doppelblindversuch
1969
·
I. Schütz
, K. L. Radenbach
, et al.
·
Lung
·
3
[Bilateral chylothorax--case report and literature review].
1991
·
R Kropp
, I Schütz
, et al.
·
PubMed
·
2
[Ambulatory chemotherapy of pulmonary tuberculosis with special reference to strictly supervised intermittent drug dosage].
1973
·
I Schütz
·
PubMed
·
2
[the Excretion of Visible, but Non-viable Tubercle Bacteria During Chemotherapy of Cavernous Pulmonary Tuberculosis].
1964
·
K BARTMANN
, I SCHUETZ
, et al.
·
PubMed
·
2
Rifampicin-Hemmtiter bei Tuberkulosebakterien-Wildstämmen und Rifampicin-Serumkonzentrationen bei Tuberkulosekranken
1969
·
H. Hussels
, I. Schütz
·
Lung
·
1
Klinische Erfahrungen mit Viomycin (Viocin-Pfizer)
1955
·
Ingeborg Schütz
·
Lung
·
1
[Evaluation of controlled clinical trials in chemotherapy of lung tuberculosis].
1987
·
I Schütz
·
PubMed
[Medical rehabilitation in diseases of the respiratory organs].
1986
·
I Schütz
, E Weis
·
PubMed
[Efficacy of oxygen therapy with the oxygen concentrator during physical exercise (author's transl)].
1981
·
I Schütz
, N Peslis
, et al.
·
PubMed
[Suggestion of the diagnosis and classification of the degree of severity of chronic non-specific respiratory diseases (author's transl)].
1979
·
H Schnieders
, R Kaliebe
, et al.
·
PubMed
[The early detection of the inadequate effect of conservative chemical treatment in cavernous pulmonary tuberculosis].
1961
·
K AUERSBACH
, K BARTMANN
, et al.
·
PubMed
[The early recognition of risk cases in conservative chemotherapy of cavenous pulmonary tuberculosis].
1960
·
K AUERSBACH
, K BARTMANN
, et al.
·
PubMed
Assessment of Prognosis in Pulmonary Tuberculosis with Cavitation by Response to Chemotherapy.
1960
·
K Auersbach
, K. Bartmann
, et al.
·
Wiener Medizinische Wochenschrift
Show more works
View as search
Works count:
20
Citation count:
78
H-index:
4
I10-index:
1
Year
Topic
Type